Health
Oxford says its candidate has great immune reaction with two dose regime – Microbioz India
The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed…
The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a complete dose, in contrast to a two full-dose regime, though more work needs to be done to affirm the outcome.
The details from the Phase I/II clinical trials released on December 17 made no reference to the half-dose/full-dose regime, which Oxford has said had been”unplanned” but accepted by regulators.
The university said it had…
-
Noosa News13 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News14 hours agoMotorcyclist dies in crash with truck
-
Noosa News14 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General19 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging